The study, which utilized mortality data from 20 low-mortality countries between 1950 and 2019, reveals a significant gender paradox in longevity trends. While men in most developed nations are moving closer to the optimal health benchmarks, women are drifting further away, despite men historically bearing a greater burden from past smoking. This divergence highlights that the role of smoking in mortality is diminishing, yet other adverse factors are increasingly preventing populations from realizing their full health potential.
The study introduces a novel method for measuring progress in survival by using time lags rather than traditional absolute or relative differences in mortality measures. The researchers defined a progress benchmark as the record smoking-eliminated life expectancy, which represents the highest observed life expectancy in a given year after removing the estimated impact of smoking. By comparing country-specific observed and smoking-eliminated life expectancy against this reference trend, the team quantified how many calendar years each country is behind the current longevity frontier. This approach allows for a dynamic assessment of developmental delays, providing a clear metric for how far back in time a country’s current life expectancy corresponds to the reference trend.
The data for the analysis were extracted from the Human Mortality Database and the WHO Mortality Database. The researchers included 20 countries with sufficient data up to 2019, excluding the period affected by the COVID-19 pandemic to focus on secular trends. The countries analyzed include Australia, Austria, Belgium, Canada, Switzerland, Germany, Denmark, Spain, Finland, France, the United Kingdom, Italy, Ireland, Japan, the Netherlands, Norway, New Zealand, Portugal, Sweden, and the United States. To estimate smoking-eliminated mortality, the team applied a modified Preston-Glei-Wilmoth approach, which uses lung cancer deaths to model the attributable fraction of deaths due to smoking from other causes. This method accounts for country, sex, age, and period interactions, providing a counterfactual estimate of longevity if smoking had not affected mortality trends.
Between 1950 and 2019, both record observed and smoking-eliminated life expectancy increased for both men and women. Record observed life expectancy rose from 73 years for women and 70 years for men in 1950 to 88 years for women and 82 years for men in 2019. However, the smoking-eliminated values were higher, reaching almost 90 years for women and 84 years for men in 2019. Japanese women have held the record for both types of life expectancy since the mid-1980s, while Japanese men appear as record holders only after eliminating the effect of smoking. Swiss men have shown the highest observed life expectancy values over the last 15 years, highlighting the varying impact of smoking on the longevity frontier for men and women.
In 2019, the time lag between country-specific life expectancy and the record smoking-eliminated benchmark revealed that most countries were behind the frontier by approximately two decades. The United States showed the greatest lag, with observed life expectancy corresponding to levels reached almost four decades ago for men and more than three decades ago for women. Even after eliminating smoking, the US lag remained substantial at 26.2 years for men and 25.2 years for women. In contrast, Italian men and Canadian women were the populations closest to the record after adjusting for smoking, with Italian men lagging only five years behind the benchmark. The reduction in the time lag after eliminating smoking was generally greater for men than for women, indicating that smoking has had a more pronounced effect on male mortality trajectories.
The study also examined changes in these time lags between 2000 and 2019, revealing distinct trends for men and women. For women, the observed lag increased in all analyzed countries, indicating that they are falling further behind the record smoking-eliminated life expectancy. Irish women were the only exception, maintaining improvements at a pace comparable to the reference trend. US women experienced the largest increase in the lag, with a rise of 12 years between 2000 and 2019. For men, the pattern was different, with most countries showing either stagnating or decreasing lags. This suggests that men are improving at a similar or faster pace than the reference trend, while women are improving more slowly. The exceptional trajectory of Japanese women, who have maintained the record for decades, underscores the difficulty for other nations to keep up with the longevity frontier.
Age-specific analysis of death rates provided further insight into where these developmental delays are concentrated. In countries with small lags in observed life expectancy, such as Spain, Australia, and Italy, death rates for children, adolescents, and adults show almost no difference from the reference trend. However, death rates at age 55 and older are 15 to 20 years behind the reference, with marked lags of around 25 years at age 85 and over. For men in the best-performing countries, almost all lags in observed death rates disappear when smoking is eliminated, particularly at younger ages. In laggard countries, such as the United States and the United Kingdom, significant delays are observed at working ages, including those below 50. These delays persist even after adjusting for smoking, suggesting that factors other than tobacco, such as the opioid crisis and obesity, are contributing to the mortality disadvantage.
The findings indicate that smoking remains a major determinant of divergent longevity trajectories, particularly for men. The almost parallel change in record smoking-eliminated and observed life expectancy for men suggests that the peak mortality impact of smoking at the frontier has already been reached. For women, the gap between observed and smoking-eliminated life expectancy has been increasing since the early 1980s, reflecting the later uptake of smoking in women. The study highlights that while the positive effects of smoking declines have not yet been fully realized, the diminishing returns from smoking reduction are becoming apparent. The persistence of developmental delays in both sexes, especially at advanced ages, points to the importance of adverse factors beyond smoking, such as chronic disease and social deprivation.
The case of Ireland provides a notable example of how sustained public health efforts can overcome smoking-related mortality disadvantages. Irish men achieved the largest reduction in lags between 2000 and 2019, with both observed and smoking-eliminated life expectancy improving faster than the record pace. This progress is attributed to Ireland’s comprehensive tobacco control program, which has been considered one of the most effective in the world. The Irish case demonstrates that populations can close the gap with the longevity frontier through targeted interventions, although the overall trend for women in other countries remains one of divergence from the benchmark.
The study acknowledges several limitations, including the exclusion of the COVID-19 pandemic years and the use of an open-ended age group for those 85 and older, which obscures detailed differences at the highest ages. The counterfactual approach to estimating smoking effects may not capture all nuances of mortality, particularly at ages below 45. Nevertheless, the lag-based approach offers a unique perspective on the temporal dimension of smoking’s impact, revealing how past smoking histories continue to shape current mortality levels and future progress. The research underscores that approaching the current health potential will depend largely on countries’ ability to manage health in old age, including the increasing burden of chronic diseases.
The temporal lag framework builds on demographic concepts originally proposed by Stolnitz in 1955 to assess survival disparities between non-Western and Western populations. In modeling these secular trajectories across the seventy-year observation window, eight different countries contributed to the record trends. Fitted linear regression estimates indicated that record smoking-eliminated life expectancy advanced by 2.5 years per decade for women and 1.9 years per decade for men. These gains surpassed the observed record increases of 2.2 years per decade for women and 1.7 years per decade for men, illustrating how removing tobacco-related mortality clarifies the expansion of the frontier over time.
Granular age-specific evaluations also highlighted distinct developmental patterns across participating nations. For instance, French women experienced pronounced mortality lags between ages 45 and 64, yet maintained the smallest lags among vanguard nations at ages 70 to 84. Conversely, Finnish and Canadian women exhibited elevated delays between ages 10 and 29. Among males, Australian men demonstrated substantial lags at working ages but minimal delays at ages 60 and above. Additionally, between 2000 and 2019, male smoking-eliminated lags remained nearly constant at around five years in Spain, Switzerland, and the Netherlands, whereas men in Sweden, Canada, Germany, and the United Kingdom saw delays increase by three to six years.
Beyond tobacco use, which accounted for 175 million deaths globally between 1990 and 2021, other health burdens increasingly restrict progress toward optimal health potential. Factors such as rising obesity, cardiovascular disease, and generational health drift marked by deteriorating health in younger cohorts present major obstacles to longevity gains. Furthermore, while long-term record trajectories have been dominated by Japanese women, the researchers observed that populations with shorter continuous historical records, such as Hong Kong and South Korea, show that benchmark levels can be approached or exceeded. These dynamics demonstrate that while reducing smoking remains essential, addressing broader chronic health conditions is vital for converging toward benchmark longevity.
Subject of Research: International comparison of national life expectancy lags and the role of smoking in mortality trends
Article Title: National Life Expectancy Lags Behind Benchmark Progress and the Role of Smoking: An International Comparison
Article References: Ebeling, M., & Peters, F. (2026). National Life Expectancy Lags Behind Benchmark Progress and the Role of Smoking: An International Comparison. European Journal of Population, 42(1), Article 1. https://doi.org/10.1007/s10680-025-09760-8
Image Credits: AI Generated
DOI: 10.1007/s10680-025-09760-8
Keywords: life expectancy, smoking, mortality, demography, gender gap, public health, longevity frontier, time lags, National, Life, Expectancy, Lags
Cite Scienmag News
Beatrice Stafford. (November 10, 2026). Men Close Longevity Gap While Women Drift Further Behind. Scienmag. https://scienmag.com/men-close-longevity-gap-while-women-drift-further-behind/
Beatrice Stafford. "Men Close Longevity Gap While Women Drift Further Behind." Scienmag, 10 November 2026, https://scienmag.com/men-close-longevity-gap-while-women-drift-further-behind/. Accessed 21 November 2026.
Beatrice Stafford. "Men Close Longevity Gap While Women Drift Further Behind." Scienmag. November 10, 2026. https://scienmag.com/men-close-longevity-gap-while-women-drift-further-behind/








